Farringdon Capital’s Repligen RGEN Stock Holding History

Farringdon Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,761	Closed	-$289K	–	554
2025 Q4	$289K	Buy	+1,761	New	+$276K	0.07%	325
2025 Q2	–	Sell	-2,506	Closed	-$319K	–	570
2025 Q1	$319K	Buy	2,506 +948	+61%	+$146K	0.16%	183
2024 Q4	$224K	Buy	+1,558	New	+$223K	0.09%	351

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Farringdon Capital's RGEN Position: Q1 2026 in Review

Farringdon Capital sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,761 shares — an estimated $289K sold.

Farringdon Capital first reported a position in RGEN in Q4 2024 and held it in 3 quarters. The position peaked at $319K in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Farringdon Capital reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 1,761 Repligen shares in Q1 2026, an estimated $289K.
Farringdon Capital first reported a position in Repligen in Q4 2024 and held it in 3 quarters.
Farringdon Capital's Repligen position peaked at $319K in Q1 2025.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.